HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masafumi Yamaguchi Selected Research

Imatinib Mesylate (Gleevec)

4/2016c-kit mutation-positive advanced thymic carcinoma successfully treated as a mediastinal gastrointestinal stromal tumor: A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masafumi Yamaguchi Research Topics

Disease

37Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 10/2002
25Neoplasms (Cancer)
05/2022 - 01/2002
14Lung Neoplasms (Lung Cancer)
12/2021 - 01/2002
13Asthma (Bronchial Asthma)
01/2017 - 03/2006
9Adenocarcinoma
04/2020 - 05/2002
7Adenocarcinoma of Lung
01/2021 - 09/2013
6Neoplasm Metastasis (Metastasis)
01/2021 - 11/2003
5Malignant Mesothelioma
01/2017 - 05/2004
5Cough
03/2012 - 04/2007
4Inflammation (Inflammations)
04/2020 - 03/2008
4Cough-Variant Asthma
01/2012 - 03/2006
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2021 - 04/2015
3Disease Progression
06/2021 - 10/2014
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 05/2002
3Thymoma (Thymic Carcinoma)
04/2016 - 10/2013
3Chronic Cough
01/2011 - 03/2009
3Respiratory Sounds (Crackle)
03/2009 - 03/2006
2Pneumonia (Pneumonitis)
05/2022 - 06/2021
2Lymphatic Metastasis
03/2021 - 04/2018
2Pain (Aches)
01/2020 - 06/2007
2Pleural Effusion (Pleural Effusions)
12/2017 - 03/2014
2Neoplasm Micrometastasis
11/2014 - 01/2002
2Respiratory Hypersensitivity
01/2012 - 01/2011
1Blister (Bulla)
06/2021
1Headache (Headaches)
01/2021
1Pulmonary Embolism
06/2020
1Small Cell Carcinoma
04/2020
1Fever (Fevers)
03/2020
1Meningitis
03/2020
1Encephalitis (Encephalitis, Rasmussen)
03/2020
1Aseptic Meningitis
03/2020
1Consciousness Disorders
03/2020
1Acute Generalized Exanthematous Pustulosis
01/2020
1Hip Osteoarthritis (Coxarthrosis)
01/2020
1Esophageal Neoplasms (Esophageal Cancer)
01/2020

Drug/Important Bio-Agent (IBA)

9Immune Checkpoint InhibitorsIBA
05/2022 - 04/2020
8ErbB Receptors (EGF Receptor)IBA
11/2020 - 09/2013
6Cisplatin (Platino)FDA LinkGeneric
04/2020 - 01/2006
5pembrolizumabIBA
05/2022 - 09/2019
5PlatinumIBA
12/2021 - 10/2013
5Methacholine Chloride (Methacholine)FDA Link
03/2012 - 11/2006
4GemcitabineFDA Link
12/2021 - 05/2010
4Tyrosine Kinase InhibitorsIBA
06/2021 - 03/2015
4Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2006
4B7-H1 AntigenIBA
01/2021 - 04/2020
4Anaplastic Lymphoma KinaseIBA
01/2020 - 09/2013
4Adrenal Cortex Hormones (Corticosteroids)IBA
12/2010 - 03/2006
3LigandsIBA
06/2021 - 01/2021
3Pharmaceutical PreparationsIBA
06/2021 - 11/2011
3Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2011
3Vinorelbine (Navelbine)FDA LinkGeneric
03/2020 - 02/2014
3AllergensIBA
03/2012 - 10/2007
3Capsaicin (Zostrix)FDA Link
01/2012 - 04/2007
2TegafurIBA
12/2021 - 11/2013
2AlbuminsIBA
06/2021 - 01/2021
2C-Reactive ProteinIBA
06/2021 - 01/2021
2amrubicinIBA
04/2020 - 10/2013
2atezolizumabIBA
04/2020 - 03/2020
2CrizotinibIBA
01/2020 - 11/2013
2Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2017 - 05/2014
2ProstaglandinsIBA
01/2017 - 01/2012
2Pemetrexed (MTA)FDA Link
06/2015 - 08/2014
2Anti-Bacterial Agents (Antibiotics)IBA
03/2015 - 03/2014
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
07/2014 - 09/2013
2Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2012 - 01/2011
2Bronchodilator Agents (Bronchodilators)IBA
01/2012 - 03/2009
2MucinsIBA
09/2011 - 05/2010
2Saline SolutionIBA
01/2006 - 06/2004
1NivolumabIBA
05/2022
1UracilIBA
12/2021
1osimertinibIBA
07/2021
1Nucleic AcidsIBA
07/2021
1Cell-Free Nucleic AcidsIBA
07/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2021
1durvalumabIBA
01/2021
1AntibodiesIBA
01/2021
1tepotinibIBA
01/2021
1lorlatinibIBA
06/2020
1Tumor Biomarkers (Tumor Markers)IBA
04/2020
1Phosphopyruvate Hydratase (Enolase)IBA
04/2020
1Irinotecan (Camptosar)FDA LinkGeneric
04/2020
1Carboplatin (JM8)FDA LinkGeneric
03/2020
1Docetaxel (Taxotere)FDA Link
03/2020
1Monoclonal AntibodiesIBA
09/2019
1AfatinibIBA
04/2018
1Dinoprostone (PGE2)FDA Link
01/2017
1Imatinib Mesylate (Gleevec)FDA Link
04/2016

Therapy/Procedure

20Therapeutics
12/2021 - 02/2003
16Drug Therapy (Chemotherapy)
12/2021 - 05/2004
10Radiotherapy
12/2021 - 05/2004
8Chemoradiotherapy
01/2021 - 10/2002
7Pneumonectomy (Lung Volume Reduction)
03/2019 - 05/2004
4Adjuvant Chemotherapy
03/2021 - 05/2010
3Segmental Mastectomy (Lumpectomy)
01/2022 - 06/2002
3Aftercare (After-Treatment)
12/2021 - 01/2012
3Lymph Node Excision (Lymph Node Dissection)
12/2017 - 03/2010
2Combined Modality Therapy
03/2021 - 05/2004
2Immunotherapy
12/2020 - 04/2020
2Sternotomy
01/2011 - 02/2006
1Hip Replacement Arthroplasty (Total Hip Replacement)
01/2020